These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35852661)

  • 1. Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina: Introduction.
    Boden WE; Kaski JC
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1005-1009. PubMed ID: 35852661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.
    Nowbar AN; Francis DP; Al-Lamee RK
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1011-1018. PubMed ID: 34417901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome.
    Cartlidge T; Kovacevic M; Navarese EP; Werner G; Kunadian V
    Heart; 2023 Sep; 109(19):1429-1435. PubMed ID: 36928242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets.
    Mohee K; Wheatcroft SB
    J Clin Pharm Ther; 2014 Aug; 39(4):331-3. PubMed ID: 24754310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of visualization of successful revascularization on chest pain and quality of life in chronic coronary syndrome: study protocol for the multi-center, randomized, controlled PLA-pCi-EBO-pilot-trial.
    Wester M; Koll F; Zeman F; Dempfle A; Koller M; Frey N; Maier LS; Sossalla S
    Trials; 2020 Oct; 21(1):838. PubMed ID: 33032655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
    Simader FA; Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Chotai S; Bual N; Khokhar A; Gohar A; Lampadakis I; Ganesananthan S; Pathimagaraj RH; Nowbar A; Davies JR; Keeble TR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Spratt JC; Williams R; Nijjer SS; Sen S; Curzen N; Sinha M; Howard JP; Cole G; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK;
    J Am Coll Cardiol; 2024 Jul; 84(1):13-24. PubMed ID: 38759906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to stable angina in patients with advanced chronic kidney disease.
    Arif H; Yadav A
    Curr Opin Nephrol Hypertens; 2021 May; 30(3):339-345. PubMed ID: 33767062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions.
    Montone RA; Rinaldi R; Niccoli G; Andò G; Gragnano F; Piccolo R; Pelliccia F; Moscarella E; Zimarino M; Fabris E; de Rosa S; Calabrò P; Porto I; Burzotta F; Grigioni F; Barbato E; Chieffo A; Capodanno D; Al-Lamee R; Ford TJ; Brugaletta S; Indolfi C; Sinagra G; Perrone Filardi P; Crea F;
    J Am Coll Cardiol; 2024 Aug; 84(8):744-760. PubMed ID: 39142729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Coronary Intervention in Stable Coronary Heart Disease -Is Less More?
    Figulla HR; Lauten A; Maier LS; Sechtem U; Silber S; Thiele H
    Dtsch Arztebl Int; 2020 Feb; 117(9):137-144. PubMed ID: 32234189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Hennigan B; Berry C; Collison D; Corcoran D; Eteiba H; Good R; McEntegart M; Watkins S; McClure JD; Mangion K; Ford TJ; Petrie MC; Hood S; Rocchiccioli P; Shaukat A; Lindsay M; Oldroyd KG
    Heart; 2020 May; 106(10):758-764. PubMed ID: 32114516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.
    Stergiopoulos K; Boden WE; Hartigan P; Möbius-Winkler S; Hambrecht R; Hueb W; Hardison RM; Abbott JD; Brown DL
    JAMA Intern Med; 2014 Feb; 174(2):232-40. PubMed ID: 24296791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
    Al-Lamee RK; Shun-Shin MJ; Howard JP; Nowbar AN; Rajkumar C; Thompson D; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik I; Bual N; Cook C; Ahmad Y; Seligman H; Sharp ASP; Gerber R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom S; Davies JE; Francis DP
    Circulation; 2019 Dec; 140(24):1971-1980. PubMed ID: 31707827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
    Sedlis SP; Jurkovitz CT; Hartigan PM; Kolm P; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; Boden WE; Weintraub WS;
    Am J Cardiol; 2013 Dec; 112(11):1703-8. PubMed ID: 24011740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual cost of stable coronary artery disease in France: A modeling study.
    Caruba T; Chevreul K; Zarca K; Cadier B; Juillière Y; Dubourg O; Sabatier B; Danchin N
    Arch Cardiovasc Dis; 2015 Nov; 108(11):576-88. PubMed ID: 26433733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.